About: David Juurlink

An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

David Juurlink (/ˈjʊərlɪŋk/ YURE-link; born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research. He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol and fentanyl. In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Jour

Property Value
dbo:abstract
  • David Juurlink (/ˈjʊərlɪŋk/ YURE-link; born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research. He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol and fentanyl. In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive. (en)
dbo:birthPlace
dbo:birthYear
  • 1968-01-01 (xsd:gYear)
dbo:nationality
dbo:occupation
dbo:stateOfOrigin
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 54386681 (xsd:integer)
dbo:wikiPageLength
  • 3467 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1124524545 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
dbp:birthPlace
  • New Glasgow, Nova Scotia, Canada (en)
dbp:nationality
dbp:occupation
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • David Juurlink (/ˈjʊərlɪŋk/ YURE-link; born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research. He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol and fentanyl. In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Jour (en)
rdfs:label
  • David Juurlink (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License